TherapeuticsMD Inc (NYSE MKT LLC:TXMD)

8.24
Delayed Data
As of 4:00pm ET
 +0.06 / +0.73%
Today’s Change
3.44
Today|||52-Week Range
8.60
+85.17%
Year-to-Date
No recent news for TherapeuticsMD Inc.

Today’s Trading

Previous close8.18
Today’s open8.18
Day’s range8.09 - 8.26
Volume1,396,691
Average volume (3 months)1,162,797
Market cap$1.4B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-63.64%
Earnings growth (this year)--
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+71.23%
P/E ratioNM
Price/Sales44.34
Price/Book25.36

Competitors

 Today’s
change
Today’s
% change
RGENRepligen Corp-1.17-2.84%
MACKMerrimack Pharmaceut...-0.12-0.99%
ZSPHZS Pharma Inc+0.84+1.49%
ACORAcorda Therapeutics ...-0.01-0.03%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$15.0M
Annual profit (last year)-$54.2M
Net profit margin-360.82%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Robert G. Finizio
President, Secretary &
Director
John C. K. Milligan
Corporate headquarters
Boca Raton, Florida

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers